MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2017$827,000
-20.3%
57,026
+1.2%
0.00%
-100.0%
Q4 2016$1,038,000
-8.4%
56,348
-5.7%
0.00%0.0%
Q3 2016$1,133,000
+53.1%
59,740
+30.2%
0.00%
Q2 2016$740,000
+26.5%
45,886
-5.8%
0.00%
Q1 2016$585,000
-18.9%
48,737
-3.8%
0.00%
Q4 2015$721,000
+20.8%
50,637
-0.9%
0.00%
Q3 2015$597,00051,0870.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
LAM GROUP, INC. 130,250$4,884,3754.79%
SHAKER INVESTMENTS LLC/OH 82,253$3,084,4881.72%
Mesirow Institutional Investment Management, Inc. 325,669$12,212,5881.33%
Portolan Capital Management 340,593$12,772,2381.22%
OBERWEIS ASSET MANAGEMENT INC/ 178,200$6,682,5001.04%
Granite Investment Partners, LLC 536,821$20,130,7880.84%
Capital Impact Advisors, LLC 15,304$573,9000.70%
Hillsdale Investment Management Inc. 155,038$5,813,9260.50%
GLOBEFLEX CAPITAL L P 89,192$3,344,7000.41%
Jackson Creek Investment Advisors LLC 25,877$9700.41%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders